摘要
目的:观察、分析复方苦参注射液联合伊班膦酸钠治疗非小细胞肺癌骨转移癌痛的临床疗效。方法:收治非小细胞肺癌骨转移患者80例,随机平分两组。观察组给予复方苦参注射液联合伊班膦酸钠治疗,参照组采取伊班膦酸钠治疗,观察、对比两组患者临床疗效。结果:观察组治疗效果、治疗后疼痛缓解情况及不良情况发生率均优于参照组,差异有统计学意义(P<0.05)。结论:复方苦参注射液联合伊班膦酸钠治疗非小细胞肺癌骨转移疼痛临床效果明显,对缓解患者疼痛、提升疗效有积极意义。
Objective:To observe the clinical effect of compound matrine injection combined with ibandronate in the treatment of bone metastasis cancer pain of non-small cell lung cancer.Methods:80 patients with bone metastasis of non-small cell lung cancer were selected.They were randomly divided into the two groups on average.The observation group was treated with compound matrine injection combined with ibandronate,while the reference group took ibandronate treatment.We observed and compared the clinical efficacy of patients in the two groups.Results:The therapeutic effect,the relief pain after treatment and the incidence of adverse events of the observation group were superior to those of the reference group(P<0.05).Conclusion:Compound matrine injection combined with ibandronate in the treatment of bone metastasis cancer pain of non-small cell lung cancer has obvious clinical effect,which has a positive significance in alleviating the pain of the patients and improving the therapeutic effect.
作者
聂宁陵
Nie Ningling(Department of Oncology,Affiliated Hospital of Yongzhou Vocational Technical College,Hunan Province 425006)
出处
《中国社区医师》
2018年第9期104-105,共2页
Chinese Community Doctors
关键词
复方苦参注射液
伊班膦酸钠
非小细胞肺癌骨转移癌痛
Compound matrine injection
Ibandronate
Bone metastasis cancer pain of non-small cell lung cancer